..4 to +8.6%). Lersivirine appeared to be generally well tolerated in these studies and appears to be suitable for coadministration with raltegravir or maraviroc without the need for dose modification...

Lack of a clinically relevant effect of an antacid on the pharmacokinetics of lersivirine